Skip to main content
SpringerLink
Log in

Tumor biology and quality of life in patients with gastric cancer

  • Chapter
Management of Gastric Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 55))

Abstract

A new beginning in the diagnosis and treatment of gastric cancer includes moving beyond focusing only on treatment of the tumor. It is the patient suffering from a tumor who asks for efficient therapy. Of course, the main task of therapy is to cure the patient, but the choice among the steadily increasing number of therapies should include the consideration of tumor biology and the quality of life.

This chapter is dedicated to Sibylle Schubert, who taught us, while dying from malignant disease under the age of 40, the blessing of the fourth dimension of quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Levin DL, Devesa SS, Godwin JD, Silverman DT, 1974. Cancer rates and risks, 2. Washington D.C.: U.S. Department of Health, Education and Welfare, U.S. Government Printing Office.

    Google Scholar 

  2. Wittes RE, Friedman M, Simon R, 1986. Some thoughts on the future of clinical trials in cancer. Cancer Treat Rep 70(2):241–250.

    PubMed  CAS  Google Scholar 

  3. Volkert R, 1987. Quality of Life. Congress Report ZFA. Allgem Med 63:578–579.

    Google Scholar 

  4. McLeod RS, Fazio VW, 1984. Quality of life with the continent ileostomy World J Surg 8(1):90–95.

    Article  PubMed  CAS  Google Scholar 

  5. Hürny C, 1987. Das gespräch in der langzeitbetreuung des krebskranken. Therapiewoche 37:2463–2470.

    Google Scholar 

  6. Lesko LM, Holland JC, 1988. Psychological issues in patients with hematological malignancies. In Supportive care in cancer patients (Senn H-J, Glaus A, Schmid L, eds). Berlin: Springer Verlag, pp. 243–270.

    Chapter  Google Scholar 

  7. Hollyday HW, Hardcastle JD, 1979. Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet 1:309–311.

    Article  Google Scholar 

  8. Holland JC, 1982. Psychological aspects of cancer. In Cancer Medicine (Holland, I.-F., Frei, E. III, eds) Philadelphia: Lea and Febiger.

    Google Scholar 

  9. Schmale AH, Morrow GR, Schmitt MH, et al., 1983. Well-being of cancer survivors. Psychosom Med 45(2):163–169.

    PubMed  CAS  Google Scholar 

  10. Vestweber K-H, Troidl H, 1989. Lebensqualität nach magenoperationen. Chirurg 60:450–453.

    PubMed  CAS  Google Scholar 

  11. Goligher C, Pulvertaft CN, Watkinson G, 1964. Controlled trial of vagotomy and antrec-tomy, and subtotal gastrectomy in elective treatment of duodenal ulcer. Br Med J 1:455.

    Article  PubMed  CAS  Google Scholar 

  12. Habu H, Saito N, Sato Y, Takeshita K, Sunagawa M, Endo M, 1988. Quality of postoperative life in gastric cancer patients seventy years of age and over. Int Surg 73:92.

    Google Scholar 

  13. Kusche J, Vestweber K-H, Troidl H, 1987. Quality of life after total gastrectomy for stomach cancer. Scand J Gastroenterol 22(Suppl. 133):96.

    Article  Google Scholar 

  14. Neff U, Grötzinger U, 1985. Lebensqualität nach gastrektomie. Helv Chir Acta 52:651.

    PubMed  CAS  Google Scholar 

  15. Raab M, Van Maercke P, Stützer H, 1987. Lebensqualität nach gastrektomie — Vergleich der magenersatzmethode nach longmire und roux. Zentralbib Chir 112:1140.

    CAS  Google Scholar 

  16. Troidl H, Kusche J, Vestweber K-H, Eypasch E, Koeppen L, Boillon B, 1987. Quality of life: An important endpoint both in surgical practice and research. J Chron Dis 40:523.

    Article  PubMed  CAS  Google Scholar 

  17. Troidl H, Kusche J, Vestweber K-H, Eypasch E, Maul, 1987. Pouch versus esophagojejun-onostomy after total gastrectomy: A randomized clinical trial World J Surg 11:699.

    Article  PubMed  CAS  Google Scholar 

  18. Wengele HP, Merz J, Buchmann P, Studer M, 1985. Prä-und postoperative befindlichkeit in derselbstbeurteilung von drei gruppen chirurgischer patienten. Chirurg 56:327.

    Google Scholar 

  19. Visick AH, 1948. A study of the failure after gastrectomy. Ann R Coll Surg Edinb 3:266.

    CAS  Google Scholar 

  20. Wood-Dauphinee S, Troidl H, 1986. Endpoints for clinical studies; conventional and innovative variables. In Principles and Practice of Research (Troidl H, Spitzer WO, McPeek B, Mulder DS, McKneally MF eds). Berlin: Springer Verlag.

    Google Scholar 

  21. Vestweber K-H, Köhler L, Eypasch E, Troidl H, 1989. Quality of life as a reason for risky therapeutical concepts— Pouch vs. simple reconstruction. Langenbecks Arch Chir Suppl. II (Kongerβ bericht).

    Google Scholar 

  22. Lygidakis NJ, 1981. Total gastrectomy for gastric carcinoma: A retrospective study of different procedures and an assessment of the new technique of gastric reconstruction. Br J Surg 68:649.

    Article  PubMed  CAS  Google Scholar 

  23. Croog et al., 1986. N Engl J Med 314(26):1657.

    Article  PubMed  CAS  Google Scholar 

  24. Cary NC, 1982. The GLM procedure. In SAS User’s Guide, pp. 133–199.

    Google Scholar 

  25. Quade D, 1966. Ann Math Stat. 37:1747–1758.

    Article  Google Scholar 

  26. Canover WJ, 1980. Practical Nonparametric Statistics, 2nd ed. New York: John Wiley.

    Google Scholar 

  27. Duncan DB, 1955. Biometrics 11:1–42.

    Article  Google Scholar 

  28. Clauβ G, Ebner H, 1979. Grundlagen der Statistik. 3. Aufl. Verlag Harri Deutsch. Thun und Frankfurt am Main.

    Google Scholar 

  29. Levine M, Gyatt G, et al., 1987. Quality of life stage II breast cancer: An instrument for clinical trials. Ontario Clinical Oncology Group in ASCO Poster Session, Atlanta, Georgia.

    Google Scholar 

  30. Beumann B, 1969. Diversities in conception of health and physical fitness. J Health Hum Behav 2:39–46.

    Article  Google Scholar 

  31. Belloc NB, Breslow L, Hochslim JR, 1970. Measurement of physical health in a general population survey. Am J Epidemiol 93/3:328–336.

    Google Scholar 

  32. Betty MJ, 1964. Quality of survival in treated patients with supratentorial gliomata. J Neurol Neurosurg Psychiat 27:556–561.

    Article  PubMed  CAS  Google Scholar 

  33. Bürge PS, Richards JDM, Thompson DS, Pankerd TAJ, Sare M, Wright P, 1975. Quality and quantity of survival in acute myeloic leukemia. Lancet 10/4:621–624.

    Article  Google Scholar 

  34. Carlens E, Dahlström NE, 1970. Comparative measurements of quality of survival of lung cancer patients after diagnosis. Scand J Resp Dis 51:268–275.

    CAS  Google Scholar 

  35. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW, 1963. Index of ADL: A standardized measure of biological function. JAMA 185:94–99.

    Article  Google Scholar 

  36. Kajitani T, et al., 1972. Treatment of gastric cancer taking rehabilitation of the patient into consideration. Gan no Rinsho (Jpn J Cancer Clin) 18:25.

    CAS  Google Scholar 

  37. Tagaki K, et al., 1978. Surgical results of gastric cancer. Shujutsu (Operation) 32:161.

    Google Scholar 

  38. Tagaki K, 1981. Stages of gastric cancer and reconstruction after surgery. In Advances in the Biosciences, Vol. 32. Gastric Cancer. (Fielding JW, Newman CE, Ford CH, Jones BG, eds). New York: Pergamon Press, pp. 191–202.

    Google Scholar 

  39. Edelstyn GA, MacRae KD, MacDonald FM, 1979. Improvement in life quality in cancer patients undergoing chemotherapy. Clin Oncol 5:43–49.

    PubMed  CAS  Google Scholar 

  40. Schipper H, 1983. Why measure quality of life? Can Med Assoc J 128:1367–1370.

    PubMed  CAS  Google Scholar 

  41. Sugerbaker PH, Barofsky I, Rosenberg SA, et al., 1982. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 91:17–23.

    Google Scholar 

  42. Denck H, Karrer K, 1984. Chirurgische Onkologie, Verlag: ‘Edition Medizin’, Weinheim: Verlag.

    Google Scholar 

  43. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH, 1948. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656.

    Article  Google Scholar 

  44. Jahn WM, 1985. Mortalität und morbidität, nachsorge und lebensqualität bei tumorpatienten mit supravestikaler harnableitung im tumorzentrum essen. Med. Diss., Essen.

    Google Scholar 

  45. Neff U, Grötzinger U, 1985. Lebensqualität nach gastrektomie. Helv Chir Acta 52:651–656.

    PubMed  CAS  Google Scholar 

  46. McNeil BJ, Weichslbaum R, Pauker SG, 1981. Speech and survivial: Tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 105:982–987.

    Article  Google Scholar 

  47. Nou E, Aberg T, 1980. Quality of survival in patients with surgically treated bronchial carcinoma. Thorax 35:255–263.

    Article  PubMed  CAS  Google Scholar 

  48. Sprich M, 1983. Überlebenszeit und lebensqualität mikrochirurgisch operierter patienten mit glioblastom. Med. Diss., Freiburg.

    Google Scholar 

  49. Sugimachi K, Maekawa S, Koga Y, Ueo H, Inokuchi K, 1986. The quality of life is sustained after operation for carcinoma of the esophagus. Surg Gynecol Obstest 162:544–546.

    CAS  Google Scholar 

  50. Morris JN, Suissa S, Sherwood S, Wright SM, Greer D, 1986. Last days: A study of the quality of life of terminally ill cancer patients. J Chron Dis 39:47–62.

    Article  PubMed  CAS  Google Scholar 

  51. Bron B, 1987. Angst und depression bei unheibar kranken und sterbenden. Dtsch Med Wschr 112:148–152.

    Article  PubMed  CAS  Google Scholar 

  52. Holland JC, Hughes Korzun A, Tross S, Silberfarb P, Perrv M, Comis R, Oster M, 1986. Comparative psychological disturbance in patients with pancreatic and gastric cancer. A J Psychiat 143:8.

    Google Scholar 

  53. van Dam FSAM, Somers R, van Beek-Couzijn AL, 1981. Quality of life: Some theoretical issues. J Clin Pharmacol 21:166–168.

    Google Scholar 

  54. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove B, 1981. Measuring the quality of life of cancer patients. J Chron Dis 34:585–597.

    Article  PubMed  CAS  Google Scholar 

  55. Teske K, Daut RL, Cleeland CS, 1983. Relationships between nurses’ observations and patients’ selfreports of pain. Pain 16:289–296.

    Article  PubMed  CAS  Google Scholar 

  56. Müller-Plettenberg D, 1987. Lebensqualität und tumorbehandlungen nach maβ. Rheinisches Ärzteblatt 3:122–125.

    Google Scholar 

  57. McPeek B, McPeek A, 1984. Formen der wiedergabe der lebensqualität in klinischen Studien. In Das Magenkarzinom (Rhode H, Troidl H, eds). Stuttgart: Thieme Verlag.

    Google Scholar 

  58. Furberg CD, Mattson ME, 1984. Lebensqualität von operierten magenkarzinom-kranken. In Das Magenkarzinom (Rhode H, Troidl H, eds). Stuttgart: Thieme Verlag.

    Google Scholar 

  59. Munster AM, 1984. Entwicklung eines psychosometrischen index zur messung der lebensqualität. In Das Mogenkarzinom (Rhode H, Troidl H, eds). Stuttgart: Thieme Verlag.

    Google Scholar 

  60. Sellschopp A, 1984. Beispiel von patienten mit hirntumoren. In Das Magenkarzinom (Rhode H, Troidl H, eds). Stuttgart: Thieme Verlag.

    Google Scholar 

  61. Rhode H, Rau E, Gebbensleben, 1984. Ergebnisse der bestimmung des lebensqualitätsindex nach spitzer in der multizentrischen magenkarzinom-TNM-studie. In Das Magenkarzinom (Rhode H, Troidl H, eds). Stuttgart: Thieme Verlag.

    Google Scholar 

  62. Studienprotokoll deutscher und österreichischer Universitätskliniken und Lehrkrankenhäuser, 1986. Therapie des Magenkarzinoms/Gastrointestinale Tumore.

    Google Scholar 

  63. Mechler B, 1989. Krebsforschung in der BRD, Aktuelle Medizin, Münch Med Wschr 131. MMV Medizin Verlag GmbH München.

    Google Scholar 

  64. Fey MF, Hesketh C, et al., 1989. Clonal allele loss in gastrointestinal cancers. Br J Cancer 59(5):750–754.

    Article  PubMed  CAS  Google Scholar 

  65. Yoshida K, Tsuda T, et al., 1989. B cell pathology including molecular pathology. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Archiv 57(5):285–290.

    PubMed  CAS  Google Scholar 

  66. Nanus DM, Kelsen DP, et al., 1989. Flow cytometry as a predictive indicator in patients with operable gastric cancer. J Clini Oncol 7(8):1105–1112.

    CAS  Google Scholar 

  67. Scivetti P, Danova M, et al., 1989. Prognostic significance of DNA content in large bowel carcinoma: A retrospective flow cytrometic study. Cancer Lett 46(3):213–219.

    Article  PubMed  CAS  Google Scholar 

  68. Yanagawa E, Nishiyama M, et al., 1989. Chemosensitivity tests in colorectal cancer patients. Jpn J Surg 19(4):432–438.

    Article  PubMed  CAS  Google Scholar 

  69. Yokota T, Masuko T, et al., 1989. A tumor-associated antigen in the scirrhous gastric carcinoma cell line MK-01 defined by monoclonal antibody S202. Jpn J Surg 19(4):452–458.

    Article  PubMed  CAS  Google Scholar 

  70. Kersey JH, Spector BD, Good RA, 1978. Primary immunodeficiency diseases and cancer registry. In Immune Defense Mechansims in Tumor Immunity. Immunology II (Bellanti, ed). Philadelphia: W.B. Saunders.

    Google Scholar 

  71. Schaefer HE, Wittekind C, 1984. Tumoranalysestudie magenkarzinom-TNM-validisierungsstudie, Freiburg.

    Google Scholar 

  72. Balch CM, 1986. Immune responses to tumor antigens and their clinical applications, Houston, Texas.

    Google Scholar 

  73. Balch CM, Itoh K, Tilden AB, 1985. Cellular immune defects in patients with melanoma involving interleukin-2-activated lymphocyte cytotoxicity and a serum suppressor factor. Birmingham, Ala.

    Google Scholar 

  74. Kurzrock R, Rosenblum MG, Quesada JR, Sherwin SA, Itri LM, Gutterman JU, 1986. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients. J Clin Oncol 4(11):1677–1683.

    PubMed  CAS  Google Scholar 

  75. Mellstedt H, Douillard JY, 1987. Monoklonale antikörper in der behandlung des kolorektalen karzinoms. Sonderdruck Deutsches Ärzteblatt-Ärztliche Mitteilungen, Heft 34/35:2244–2245.

    Google Scholar 

  76. Fonatsch C, 1989. Entwicklungen der cytogenetik maligner tumore. Klin Wochen Suppl. XVI:5–7 XVI. S

    Google Scholar 

  77. zur Hausen H, 1989. Tumorsuppressorgene — Bestehen möglichkeiten ihres therapeutischen einsatzes? Deutsches krebsforschungszentrum heidelberg. Klin Wochen Suppl. XVI:7.

    Google Scholar 

  78. Yamada Y, Kato Y, 1989. Greater tendency for submocosal invasion in fundic area of gastric carcinomas than those arising in the pyloric area. Cancer 63:1757–1760.

    Article  PubMed  CAS  Google Scholar 

  79. Vollmers HP, O’Connor, R, et al., 1989. SC-1, a functional human monoclonal antibody against autologous stomach carcinoma cells. Cancer Res 49:2471–2476.

    PubMed  CAS  Google Scholar 

  80. Adler R, Hemmeler W, 1986. Theorie und praxis zur anamnese. Der Bio-Psycho-Soziale Zugang zur Krankheit. Stuttgart: Fischer.

    Google Scholar 

  81. Herschbach P, 1985. Pschosoziale Probleme und Bewältigungsstrategien von Brust-und Genital-krebspatientinnen. München: Röttger.

    Google Scholar 

  82. Nagel GA, 1974. Heibare und unheilbare krebsformen: Konsequenzen für behandlung und lehre Praxis 63:1188–1195.

    CAS  Google Scholar 

  83. Siegrist J, 1982. Asymmetrische kommunikation bei klinischen visiten. In Das Gespräch Während der Ärztlichen Visite (Köhle K, Raspe HH, eds). München: Urban und Schwarzenberg, pp. 16–22.

    Google Scholar 

  84. Sanes S, 1979. A Physician Faces Cancer in himself. Albany, NY: State University of New York Press.

    Google Scholar 

  85. Goldberg RJ, 1984. Disclosure of information to adult cancer patients: Issues and update. J Clin Oncol 2(8):948–955.

    PubMed  CAS  Google Scholar 

  86. Schmale J, Weinberg N, Pieper S, 1987. Satisfactions, stresses and coping mechanisms of oncologists in clinical practice. Psychosocial aspects of cancer/supportive care. Poster Session ASCO Meeting, Atlanta, Georgia.

    Google Scholar 

Download references

Authors
  1. E. Rau
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Cancer Institute, Washington Hospital Center, Washington, DC, USA

    Paul H. Sugarbaker M.D., FACS

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rau, E. (1991). Tumor biology and quality of life in patients with gastric cancer. In: Sugarbaker, P.H. (eds) Management of Gastric Cancer. Cancer Treatment and Research, vol 55. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3882-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3882-0_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6731-4

  • Online ISBN: 978-1-4615-3882-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation